James J. Dignam

Analysis of Cause-Specific Events in Competing Risks Survival Data

John Bryant, James J. Dignam, H.Sam Wieand, 2003, Advances in Survival Analysis.

editorial Building Firm Foundations for Therapy Development

James J. Dignam, Theodore Karrison, J. Dignam, 2015 .

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07.

Greg Yothers, Clifton D. Fuller, Mehee Choi, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Olufunmilayo I. Olopade, Mark W. Lingen, Everett E. Vokes, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.

Early Stopping of Cancer Clinical Trials

James J. Dignam, John Bryant, H. Samuel Wieand, 2005 .